Skip to main content

Advertisement

Log in

CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study is to investigate the effects of CIP2A (Cancerous inhibitor of protein phosphatase 2A) on the apoptosis of RA FLS. Proliferation and apoptotic activity of RA FLS following treatment with CIP2A siRNA or control siRNA were analyzed using MTT assays and Cell Death Detection kit. RA FLS was treated with CIP2A siRNA or control siRNA in 3-, 6-, and 9-day intervals for a Western blot analysis to determine C-Myc expression. To evaluate the signal transduction pathways engaged in apoptosis, caspase-3 activity, caspase-9 activity, PARP, and phosphorylation of the Akt kinase were analyzed by Western blot. Cell viability of RA FLS was significantly lower in the CIP2A siRNA-treated group compared with the control after 7 days (p = 0.022). Apoptosis of RA FLS was significantly higher in the CIP2A siRNA-treated group compared with the control when incubated for 3, 6, and 9 days (p = 0.029, p = 0.021, p = 0.043, respectively). C-Myc expression did not change with the different incubation periods. CIP2A siRNA-treated FLS expressed higher level of activated caspase-3, caspase-9, and PARP (p = 0.014, p = 0.020, p = 0.021, respectively) and lower level of phosphorylated Akt (p = 0.001) compared with those treated with the control siRNA. Our data show that CIP2A expression in RA FLS is an important mediator of dysfunctional apoptosis independent of c-Myc stabilization. Expression of CIP2A may contribute to apoptotic resistance of RA FLS through the activation of Akt and deactivation of caspase-3, caspase-9, and PARP. Inhibition of CIP2A may therefore constitute a novel, promising therapeutic target in RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bresnihan B, Tak PP, Emery P, Klareskog L, Breedveld F (2000) Synovial biopsy in arthritis research: five years of concerted European collaboration. Ann Rheum Dis 59:506–511

    Article  PubMed  CAS  Google Scholar 

  2. Tak PP, Bresnihan B (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 43:2619–2633

    Article  PubMed  CAS  Google Scholar 

  3. Dhaouadi T, Sfar I, Abelmoula L, Jendoubi-Ayed S, Aouadi H, Ben Abdellah T, Ayed K, Zouari R, Gorgi Y (2007) Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review. Tunis Med 85:991–998

    PubMed  Google Scholar 

  4. Ammitzboll CG, Thiel S, Ellingsen T, Deleuran B, Jorgensen A, Jensenius JC, Stengaard-Pedersen K (2012) Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis. Rheumatol Int 32:1457–1463

    Article  PubMed  CAS  Google Scholar 

  5. Wright HL, Moots RJ, Bucknall RC, Edwards SW (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49:1618–1631

    Article  CAS  Google Scholar 

  6. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD (2011) Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 31:153–164

    Article  PubMed  CAS  Google Scholar 

  7. Bartok B, Firestein GS ( 2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233–255

    Google Scholar 

  8. Firestein GS (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 39:1781–1790

    Article  PubMed  CAS  Google Scholar 

  9. Firestein GS, Yeo M, Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631–1638

    Article  PubMed  CAS  Google Scholar 

  10. Junttila MR, Puustinen P, Niemela M, Ahola R, Arnold H, Bottzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grenman R, Kast J, Kallunki T, Sears R, Kahari VM, Westermarck J (2007) CIP2A inhibits PP2A in human malignancies. Cell 130:51–62

    Article  PubMed  CAS  Google Scholar 

  11. Come C, Laine A, Chanrion M, Edgren H, Mattila E, Liu X, Jonkers J, Ivaska J, Isola J, Darbon JM, Kallioniemi O, Thezenas S, Westermarck J (2009) CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15:5092–5100

    Article  PubMed  CAS  Google Scholar 

  12. Li W, Ge Z, Liu C, Liu Z, Bjorkholm M, Jia J, Xu D (2008) CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res 14:3722–3728

    Article  PubMed  CAS  Google Scholar 

  13. Lee J, Park EJ, Hwang JW, Oh JM, Kim H, Bae EK, Choi YL, Han J, Ahn JK, Cha HS, Koh EM (2012) CIP2A expression is associated with synovial hyperplasia and invasive function of fibroblast-like synoviocytes in rheumatoid arthritis. Rheumatol Int 32:2023–2030

    Article  PubMed  CAS  Google Scholar 

  14. Case JP, Sano H, Lafyatis R, Remmers EF, Kumkumian GK, Wilder RL (1989) Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats. J Clin Invest 84:1731–1740

    Article  PubMed  CAS  Google Scholar 

  15. Waalen K, Sioud M, Natvig JB, Forre O (1992) Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes. Scand J Immunol 36:865–873

    Article  PubMed  CAS  Google Scholar 

  16. Qu Z, Garcia CH, O’Rourke LM, Planck SR, Kohli M, Rosenbaum JT (1994) Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum 37:212–220

    Article  PubMed  CAS  Google Scholar 

  17. Asahara H, Hasunuma T, Kobata T, Inoue H, Muller-Ladner U, Gay S, Sumida T, Nishioka K (1997) In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium. J Rheumatol 24:430–435

    PubMed  CAS  Google Scholar 

  18. Hashiramoto A, Sano H, Maekawa T, Kawahito Y, Kimura S, Kusaka Y, Wilder RL, Kato H, Kondo M, Nakajima H (1999) C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Arthritis Rheum 42:954–962

    Article  PubMed  CAS  Google Scholar 

  19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  20. Firestein GS (2009) Etiology and pathogenesis of rheumatoid arthritis. In: Firestein GS, Budd RC, Harris T, McInnes IB, Ruddy S, Sergent JS (eds) Kelly’s textbook of rheumatology. Saunders Elsevier, Philadelphia, pp 1035–1086

    Chapter  Google Scholar 

  21. Pap T, Gay S (2009) Fibroblasts and fibroblast-like synoviocytes. In: Firestein GS, Budd RC, Harris T, McInnes IB, Ruddy S, Sergent JS (eds) Kellly’s text book of rheumatology, 8th edn. Saunders Elsevier, Philadelphia, pp 201–214

    Chapter  Google Scholar 

  22. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485–491

    Article  PubMed  CAS  Google Scholar 

  23. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94:10895–10900

    Article  PubMed  CAS  Google Scholar 

  24. Reme T, Travaglio A, Gueydon E, Adla L, Jorgensen C, Sany J (1998) Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol 111:353–358

    Article  PubMed  CAS  Google Scholar 

  25. Imamura F, Aono H, Hasunuma T, Sumida T, Tateishi H, Maruo S, Nishioka K (1998) Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum 41:1979–1986

    Article  PubMed  CAS  Google Scholar 

  26. Schedel J, Gay RE, Kuenzler P, Seemayer C, Simmen B, Michel BA, Gay S (2002) FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum 46:1512–1518

    Article  PubMed  CAS  Google Scholar 

  27. Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Muller-Ladner U, Gay RE, Gay S (2000) Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 43:599–607

    Article  PubMed  CAS  Google Scholar 

  28. Lim DS, Bae YS (2011) Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis. Rheumatol Int 31:843–847

    Article  PubMed  CAS  Google Scholar 

  29. Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 23:1345–1352

    PubMed  CAS  Google Scholar 

  30. Perlman H, Georganas C, Pagliari LJ, Koch AE, Haines K 3rd, Pope RM (2000) Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 164:5227–5235

    PubMed  CAS  Google Scholar 

  31. Janssens V, Goris J (2001) Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353:417–439

    Article  PubMed  CAS  Google Scholar 

  32. Pap T, Nawrath M, Heinrich J, Bosse M, Baier A, Hummel KM, Petrow P, Kuchen S, Michel BA, Gay RE, Muller-Ladner U, Moelling K, Gay S (2004) Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum 50:2794–2802

    Article  PubMed  CAS  Google Scholar 

  33. Anders M, Krohn K, Kroger H, Huser H, Sparmann M, Meissner A, Gombert W (1991) Proto-oncogene expression in cultured synovial fibroblasts of patients with rheumatoid arthritis. Mol Cell Probes 5:207–213

    Article  PubMed  CAS  Google Scholar 

  34. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K (1996) Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 55:442–449

    Article  PubMed  CAS  Google Scholar 

  35. Li R, Cai L, Xie XF, Peng L, Li J (2010) 7,3’-dimethoxy hesperetin induces apoptosis of fibroblast-like synoviocytes in rats with adjuvant arthritis through caspase 3 activation. Phytother Res 24:1850–1856

    Article  PubMed  CAS  Google Scholar 

  36. Mei Y, Zheng Y, Wang H, Gao J, Liu D, Zhao Y, Zhang Z (2011) Arsenic trioxide induces apoptosis of fibroblast-like synoviocytes and represents antiarthritis effect in experimental model of rheumatoid arthritis. J Rheumatol 38:36–43

    Article  PubMed  CAS  Google Scholar 

  37. Yokota K, Miyoshi F, Miyazaki T, Sato K, Yoshida Y, Asanuma Y, Akiyama Y, Mimura T (2008) High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 35:193–200

    PubMed  CAS  Google Scholar 

  38. Ito T, Deng X, Carr B, May WS (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671–11673

    Article  PubMed  CAS  Google Scholar 

  39. Ruvolo PP, Deng X, Ito T, Carr BK, May WS (1999) Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 274:20296–20300

    Article  PubMed  CAS  Google Scholar 

  40. Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S (2000) Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2:59–64

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the grants from Samsung Biomedical Research Institute [grant number SBRI C-B0-203-1].

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eun-Mi Koh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, J., Jeong, H., Park, EJ. et al. CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression. Rheumatol Int 33, 2241–2248 (2013). https://doi.org/10.1007/s00296-013-2711-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2711-6

Keywords

Navigation